Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
123,754,217
-
Share change
-
+3,827,655
-
Total reported value
-
$34,035,461,284
-
Put/Call ratio
-
92%
-
Price per share
-
$275.03
-
Number of holders
-
559
-
Value change
-
+$1,116,635,795
-
Number of buys
-
313
-
Number of sells
-
224
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q3 2024
As of 30 Sep 2024 ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) had 559 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 123,754,217 shares of stock of the company.
Largest 10 holders included Capital World Investors, FMR LLC, VANGUARD GROUP INC, BlackRock, Inc., Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, BAILLIE GIFFORD & CO, Capital International Investors, Dodge & Cox, and STATE STREET CORP.
This table shows 559 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.